We investigated early local changes induced by recombinant human bone morphogenetic protein (rhBMP)-2 and a novel carrier, poly[L-lactide-co-glycolide] copolymer-coated gelatin sponge (PGS). A 1.5 cm segmental bone defect was created in the diaphysis of the right ulna of male Japanese white rabbit. Defects received PGS with or without rhBMP-2 (0, 0.4, or 1 mg/cm3) and were harvested at 3, 7, 14, 21, or 28 days post implantation for histological examination. Immuno-staining for vascular endothelial growth factor (VEGF) was also performed. Spindle-shaped cells were observed in the rhBMP-2-treated groups 3 and 7 days after implantation. Bone regeneration was detected after 14 days in the rhBMP-2-treated groups and the bone area increased with time and dose. Expression of VEGF was observed in all groups at 3 days and was maintained by 14 days only in the defects treated with rhBMP-2 at a dose of 1 mg. These results indicate that rhBMP-2 exert its osteo-inductive activities via the promotion of osteogenic cell mobilization, and possibly via angiogenesis based on VEGF induction. Foreign-body reactions to the implanted PGS were similar to those observed when either poly[L-lactide-co-glycolide] copolymer or gelatin was individually implanted. These results indicate that the PGS is a useful and safe carrier for rhBMP-2.
Iwaki, A., Jingushi, S., Oda, Y., Izumi, T., Shida, J., Tsuneyoshi, M. et al. (1997). Localization of Proliferating Cells during Rat Fracture Repair: Detection of Proliferating Cell Nuclear Antigen by Immunohistochemistry , J. Bone Miner. Res., 12: 96-102.
2.
Glowacki, J. (1998). Angiogenesis in Fracture Repair, Clin. Orthop., 355S: S82-89.
3.
Gerber, H.S. and Ferrara, N. (2000). Angiogenesis and Bone Growth, Trends. Cardiovasc. Med., 10: 223-228.
4.
Street, J., Bao, M., de Guzman, L., Bunting, S., Peale, F.V., Ferrara, N. et al. (2002). Vascular Endothelial Growth Factor Stimulates Bone Repair by Promoting Angiogenesis and Bone Turnover, Proc. Natl. Acad. Sci. U.S.A., 99: 9656-9661.
5.
Hausman, M.R. , Schaffler, M.B. and Majeska, R.J. (2001). Prevention of Fracture Healing in Rats by an Inhibitor of Angiogenesis, Bone, 29: 560-564.
6.
Brighton, C.T. and Hunt, R.M. (1991). Early Histological and Ultrastructural Changes in Medullary Fracture Callus, J. Bone Joint Surg., 73A: 832-847.
7.
Erlebacher, A. , Filvaroff, E.H., Gitelman , S.E. and Derynck, R. (1995). Toward a Molecular Understanding of Skeletal Development, Cell, 80: 371-378.
8.
Gerber, H.-P. , Vu, T.H., Ryan , A.M., Kowalski, J., Werb, Z. and Ferrara, N. (1999). VEGF Couples Hypertrophic Cartilage Remodeling, Ossification and Angiogenesis during Endochondral Bone Formation, Nature Med., 5: 623-628.
9.
Welch, R.D., Jones, A.L., Bucholz, R.W., Reinert, C.M., Tjia, J.S., Pierce, W.A. et al. (1998). Effect of Recombinant Human Bone Morphogenetic Protein-2 on Fracture Healing in a Goat Tibial Fracture Model, J. Bone Miner. Res., 13: 1483-1490.
10.
Bax, B.E. , Wozney, J.M. and Ashhurst, D.E. (1999). Bone Morphogenetic Protein-2 Increases the Rate of Callus Formation after Fracture of the Rabbit Tibia, Calcif. Tissue Int., 65: 83-89.
11.
Bouxsein, M.L. , Turek, T.J., Blake , C.A., D'Augusta, D., Li , X., Stevens, M. et al. (2001 ). Recombinant Human Bone Morphogenetic Protein-2 Accelerates Healing in a Rabbit Ulnar Osteotomy Model, J. Bone Joint Surg. , 83A: 1219-1230.
12.
Luppen, C.A. , Blake, C.A., Ammirati , K.M., Stevens, M.L., Seeherman, H.J., Wozney, J.M. et al. (2002 ). Recombinant Human Bone Morphogenetic Protein-2 Enhances Osteotomy Healing in Glucocorticoid-treated Rabbits, J. Bone Miner. Res., 17: 301-310.
13.
Bostrom, M. , Lane, J.M., Tomin , E., Browne, M., Berberian, W., Turek, T. et al. (1996). Use of Bone Morphogenetic Protein-2 in the Rabbit Ulnar Nonunion Model, Clin . Orthop. , 327: 272-282.
14.
Zegzula, H.D. , Buck, D.C., Brekke , J., Wozney, J.M. and Hollinger , J.O. (1997). Bone Formation with use of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) , J. Bone Joint Surg., 79A: 1778-1790.
15.
Kokubo, S., Fujimoto, R., Yokota, S., Fukushima, S., Nozaki, K., Takahashi, K. et al. (2003). Bone Regeneration by Recombinant Human Bone Morphogenetic Protein-2 and a Novel Biodegradable Carrier in Rabbit Ulnar defect Model, Biomaterials, 24: 1643-1651.
16.
Itoh, T., Mochizuki, M., Nishimura, R., Matsunaga, S., Kadosawa, T., Kokubo, S. et al. (1998). Repair of Ulnar Segmental defect by Recombinant Human Bone Morphogenetic Protein-2 in Dogs, J. Vet. Med. Sci. , 60: 451-458.
17.
Thies, R.S. , Bauduy, M., Ashton , B.A., Kurtzberg, L., Wozney, J.M. and Rosen, V. (1992). Recombinant Human Bone Morphogenetic Protein-2 Induces Osteoblastic Differentiation in W-20-17 Stromal Cells, Endocrinology, 130: 1318-1324.
18.
Yamaguchi, A. , Ishizuya, T., Kintou , N., Wada, Y., Katagiri, T., Wozney, J.M. et al. (1996 ). Effects of BMP-2, BMP-4, and BMP-6 on Osteoblastic Differentiation of Bone Marrow-derived Cell Lines, ST2 and MC3T3-G2/ PA6, Biochem. Biophys. Res. Commun. , 220: 366-371.
19.
Yamaguchi, A. , Katagiri, T., Ikeda , T., Wozney, J.M., Rosen, V., Wang, E.A. et al. (1991). Recombinant Human Bone Morphogenetic Protein-2 Stimulates Osteoblastic Maturation and Inhibits Myogenic Differentiation in vitro, J. Cell. Biol. , 113: 681-687.
20.
Katagiri, T. , Yamaguchi, A., Komaki, M., Abe, E., Takahashi, N., Ikeda, T. et al. (1994). Bone Morphogenetic Protein-2 Converts the Differentiation Pathway of C2C12 Myoblasts into the Osteoblast Lineage, J. Cell. Biol., 127: 1755-1766.
21.
Takuwa, Y., Ohse, C., Wang, E.A., Wozney, J.M. and Yamashita, K. (1991). Bone Morphogenetic Protein-2 Stimulates Alkaline Phosphatase Activity and Collagen Synthesis in Cultured Osteoblastic Cells, MC3T3-E1, Biochem. Biophys. Res. Commun., 174: 96-101.
22.
Lind, M., Eriksen, E.F. and Bünger, C. (1996). Bone Morphogenetic Protein-2 but not bone Morphogenetic Protein-4 and -6 Stimulates Chemotactic Migration of Human Osteoblasts, Human Marrow Osteoblasts, and U2-OS Cells, Bone, 18: 53-57.
23.
Zhou, D., Zhao, K., Li, Y., Cui, F.Z. and Lee, I. (2006). Repair of Segmental Defects with Nano-hydroxyapatite/Collagen/PLA Composite Combined with Mesenchymal Stem Cells, J. Bioact. Compat. Polym., 21: 373-384.
24.
Deckers, M.M. , Bezooijen, R.L., Horst , G., Hoogendam, J., Bent, C., Papapoulos, S.E. et al. ( 2002). Bone Morphogenetic Proteins Stimulate Angiogenesis Through Osteoblast-derived Vascular Endothelial Growth Factor A, Endocrinol., 143: 1545-1553.
25.
Miyamoto, S. , Takaoka, K., Okada , T., Yoshikawa, H., Hashimoto, J., Suzuki, S. et al. (1993). Polylactic Acid-Polyethylene Glycol Block Copolymer. A New Biodegradable Synthetic Carrier for Bone Morphogenetic Protein, Clin. Orthop., 294: 333-43.
26.
Miyamoto, S. , Takaoka, K., Okada , T., Yoshikawa, H., Hashimoto, J., Suzuki, S. et al. (1992). Evaluation of Polylactic Acid Homopolymers as Carriers for Bone Morphogenetic Protein, Clin . Orthop., 278: 274-85.
27.
Yokota, S., Sonohara, R., Yoshida, M., Murai, M., Shimokawa, S., Fujimoto, R. et al. (2001). A New Recombinant Human Bone Morphogenetic Protein-2 Carrier for Bone Regeneration, Int. J. Pharm., 223: 69-79.
28.
Nagao, H., Tachikawa, N., Miki, T., Oda, M., Mori, M., Takahashi, K. et al. (2002). Effect of Recombinant Human Bone Morphogenetic Protein-2 on Bone Formation in Alveolar Ridge Defects in Dogs, Int. J. Oral Maxillofac. Surg., 31: 66-72.
29.
Cook, S.D., Baffes, G.C., Wolfe, M.W., Sampath, T.K., Rueger, D.C. and Whitecloud, T.S. (1994). The Effect of Recombinant Human Osteogenic Protein-1 on Healing of Large Segmental Bone Defects, J. Bone Joint Surg., 76A: 827-838.
30.
Hay, E., Hott, M., Graulet, A.-M., Lomri, A. and Marie, P. (1999). Effects of Bone Morphogenetic Protein-2 on Human Neonatal Calvaria Cell Differentiation, J. Cell Biochem., 72: 81-93.
31.
Bosch, P., Musgrave, D.S., Lee, J.Y., Cummins, J., Shuler, F., Ghivizzani, S.C. et al. (2000). Osteoprogenitor Cells within Skeletal Muscle , J. Orthop. Res., 18: 933-934.
32.
Mayr-Wohlfart, U., Waltenberger, J., Hausser , H., Kessler, S., Günther, K.P., Dehio, C. et al. (2002). Vascular Endothelial Growth Factor Stimulates Chemotactic Migration of Primary Human Osteoblasts , Bone, 30: 472-477.
33.
Gospodarowicz, D., Abraham, J.A. and Schilling , J. (1989). Isolation and Characterization of a Vascular Endothelial Cell Mitogen Produced by Pituitary-derived Folliculo Stellate Cells, Proc. Natl. Acad. Sci. U.S.A., 86: 7311-7315.
34.
Keck, P.J., Hauser, S.D., Krivi, G., Sanzo, K., Warren, T., Feder, J. et al. (1989). Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF, Science, 246: 1309-1312.
35.
Peng, H., Usas, A., Olshanski, A., Ho, A.M., Gearhalt, B., Cooper, G.M. et al. (2005). VEGF Improves, Whereas sFlt1 inhibits, BMP2-induced Bone Formation and Bone Healing Through Modulation of Angiogenesis , J. Bone Miner. Res., 20: 2017-2027.
36.
Rissanen, T.T. , Vajanto, I., Hiltunen , M.O., Rutanen, J., Kettunen, M.I., Niemi, M. et al. (2002). Expression of Vascular Endothelial Growth Factor Receptor-2 (KDR/Flk-1) in Ischemic Skeletal Muscle and its Regeneration, Am. J. Pathol. , 160: 1393-1403.
37.
Xiong, M., Elson, G., Legarda, D. and Leibovich, S.J. (1998). Production of Vascular Endothelial Growth Factor by Murine Macrophages, Am. J. Pathol., 153: 587-598.
38.
Fujii, T., Yonemitsu, Y., Onimaru, M., Tanii, M., Nakano, T., Egashira, K. et al. (2006). Nonendothelial Mesenchymal Cell-derived MCP-1 Required for FGF-2-Mediated Therapeutic Neovascularization, Arterioscler . Thromb. Vasc. Biol., 26: 2483-2489.
39.
Verhoeckx, K.C.M., Doornbos, R., Witkamp , R.F., Greef, J. and Rodenburg, R.J.T. (2006). Beta-adrenergic Receptor Agonists Induce the Release of Granulocyte Chemotactic Protein-2, Oncostatin M, and Vascular Endothelial Growth Factor from Macrophages , Int. Immunopharmacol., 6: 1-7.
40.
Kakudo, N., Kusumoto, K., Wang, Y.B., Iguchi, I. and Ogawa, Y. (2006). Immunolocalization of Vascular Endothelial Growth Factor on Intramuscular Ectopic Osteoinduction by Bone Morphogenetic Protein-2 , Life Sci., 79: 1847-1855.
41.
Wozney, J.M. and Rosen, V. (1998). Bone Morphogenetic Protein and Bone Morphogenetic Protein Gene Family in Bone Formation and Repair, Clin . Orthop. , 346: 26-37.
42.
Cunningham, N.S. , Paralkar, V. and Reddi, A.H. (1992). Osteogenin and Recombinant Bone Morphogenetic Protein 2B are Chemotactic for Human Monocytes and Stimulate Transforming Growth Factor β1 mRNA Expression, Proc. Natl. Acad. Sci. U.S.A., 89: 11740-11744.
43.
Ranne, T., Tirri, T., Yli-Urpo, A., Närhi, T.O., Laine, V.J., Rich, J. et al. (2007). In Vivo Behavior of Poly(∈-Caprolactone-co-DL-Lactide)/Bioactive Glass Composites in Rat, J. Bioact. Compat. Polym., 22: 249-264.
44.
Meikle, M.C. , Papaioannou, S., Ratledge, T.J., Speight, M., Watt-Smith, S.R., Hill, P.A. et al. (1994). Effect of Poly DL-lactide-co-Glycolide Implants and Xenogeneic Bone Matrix-Derived Growth Factors on Calvarial Bone Repair in the Rabbit, Biomaterials , 15: 513-521.
